Crossref

1. TACE Plus Lenvatinib Versus TACE Plus Sorafenib for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Prospective Cohort Study

- Biao Yang

- Luo Jie

- Ting Yang

- Mingyang Chen

- Yuemei Gao

- Tian Zhang

- Yuzu Zhang

- Hao Wu

- Zhengyin Liao

2. Health-related quality of life in primary hepatic cancer: a systematic review assessing the methodological properties of instruments and a meta-analysis comparing treatment strategies

- Kerstin Wohlleber

- Patrick Heger

- Pascal Probst

- Christoph Engel

- Markus K. Diener

- André L. Mihaljevic

3. Hepatocellular Carcinoma is an Emerging Issue Now in Iran

- Seyed Moayed Alavian

4. Advances in the Ablative Management of Hepatocellular Carcinoma

- Beau B. Toskich

- Ryan E. Bailey

- Sadeer J. Alzubaidi

- Zlatko Devcic

- Gregory T. Frey

- Andrew R. Lewis

- Michael R. Moynagh

- Kabir Mody

- Charles A. Ritchie

- Terence T. Sio

- Tushar Patel

- Ricardo Paz-Fumagalli

5. Review of clinical tumor ablation advance in Asia

- Luo Wang

- Jinshun Xu

- Jie Yu

- Ping Liang

6. Value of quality of life analysis in liver cancer: A clinician’s perspective

- Leung Li

- Winnie Yeo

7. Contemporary Systematic Review of Health-Related Quality of Life Outcomes in Locoregional Therapies for Hepatocellular Carcinoma

- Arighno Das

- Ahmed Gabr

- Daniel P. O’Brian

- Ahsun Riaz

- Kush Desai

- Bartley Thornburg

- Joseph R. Kallini

- Samdeep Mouli

- Robert J. Lewandowski

- Riad Salem

8. Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know?

- Jingxin Yan

- Ting Li

- Manjun Deng

- Haining Fan